HK1102563A1 - Stabilized interferon liquid formulations - Google Patents

Stabilized interferon liquid formulations

Info

Publication number
HK1102563A1
HK1102563A1 HK07110897.6A HK07110897A HK1102563A1 HK 1102563 A1 HK1102563 A1 HK 1102563A1 HK 07110897 A HK07110897 A HK 07110897A HK 1102563 A1 HK1102563 A1 HK 1102563A1
Authority
HK
Hong Kong
Prior art keywords
liquid formulations
stabilized interferon
interferon liquid
stabilized
formulations
Prior art date
Application number
HK07110897.6A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Rio Alessandra Del
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of HK1102563A1 publication Critical patent/HK1102563A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK07110897.6A 2004-06-01 2007-10-09 Stabilized interferon liquid formulations HK1102563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04076626 2004-06-01
US61637804P 2004-10-06 2004-10-06
PCT/EP2005/052414 WO2005117949A1 (en) 2004-06-01 2005-05-27 Stabilized interferon liquid formulations

Publications (1)

Publication Number Publication Date
HK1102563A1 true HK1102563A1 (en) 2007-11-30

Family

ID=34928261

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07110897.6A HK1102563A1 (en) 2004-06-01 2007-10-09 Stabilized interferon liquid formulations

Country Status (15)

Country Link
US (1) US7731948B2 (zh)
EP (1) EP1750751B1 (zh)
JP (1) JP4988562B2 (zh)
CN (1) CN1993139B (zh)
AU (1) AU2005249233B2 (zh)
BR (1) BRPI0510526A (zh)
CA (1) CA2567310A1 (zh)
EA (1) EA010979B1 (zh)
ES (1) ES2418833T3 (zh)
HK (1) HK1102563A1 (zh)
IL (1) IL179620A (zh)
MX (1) MXPA06014078A (zh)
NO (1) NO20065860L (zh)
UA (1) UA92146C2 (zh)
WO (1) WO2005117949A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004298781B2 (en) 2003-12-11 2010-04-01 Ares Trading S.A. Stabilized interferon liquid formulations
CN1984673A (zh) * 2004-05-17 2007-06-20 阿雷斯贸易股份有限公司 干扰素水凝胶制剂
CA2571800A1 (en) * 2005-12-23 2007-06-23 Canadian Blood Services Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction
TW200806317A (en) * 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
WO2008066322A1 (en) * 2006-11-28 2008-06-05 Daewoong Co., Ltd. A stable hsa-free and antioxidant-free pharmaceutical composition comprising interferon-beta
US7951368B2 (en) 2007-06-25 2011-05-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
SI2234645T1 (sl) 2007-12-20 2012-07-31 Merck Serono Sa Formulacije peg interferon beta
CA2794929C (en) * 2010-03-01 2018-06-05 Progenics Pharmaceuticals, Inc. Concentrated protein formulations and uses thereof
US20120269770A1 (en) * 2010-11-22 2012-10-25 Mark Brader Stable Preserved Compositions of Interferon-Beta
KR102050339B1 (ko) 2011-03-15 2019-11-29 바이오젠 엠에이 인코포레이티드 빠른 적정 단계식 증가 투여 요법을 이용한 인터페론의 근육내 투여와 관련된 독감 유사 증상의 감소 방법
RU2527701C1 (ru) * 2013-05-24 2014-09-10 Федеральное государственное бюджетное учреждение "Научный центр реконструктивной и восстановительной хирургии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НЦРВХ" СО РАМН) Способ приготовления средства, обладающего свойством стимуляции регенерации хрящевой, костной, мышечной тканей и способ стимуляции регенерации хрящевой, костной, мышечной тканей с использованием приготовленного средства
AU2015239104B2 (en) 2014-04-04 2018-12-20 Ares Trading S.A. Novel IFN beta protein analogs
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN114053397B (zh) * 2022-01-17 2022-12-20 北京三元基因药业股份有限公司 一种稳定的干扰素多剂量注射液及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3380726D1 (en) 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4469228A (en) 1983-05-31 1984-09-04 Schering Corporation Interferon kit
US4636383A (en) 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4879111A (en) 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
IT1244511B (it) 1991-04-15 1994-07-15 Isi Ist Sierovaccinogeno Ital Idrogeli a base di policarbossilati sintetici e proteine per il rilascio controllato di farmaci e procedimento per la loro preparazione.
KR960009385B1 (en) * 1993-11-24 1996-07-18 Samsung Bp Chemicals Co Ltd Apparatus and method for wastewater treatment by activated sludge process type
IT1272252B (it) 1994-05-16 1997-06-16 Applied Research Systems Formulazioni liquide di interferone beta
JP2758154B2 (ja) 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
US5858001A (en) 1995-12-11 1999-01-12 Elan Medical Technologies Limited Cartridge-based drug delivery device
JP2002512597A (ja) 1996-12-20 2002-04-23 アルザ コーポレイション 注射可能な貯留槽ゲル組成物およびこの組成物の製造方法
US6013253A (en) 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
EP1017413B2 (de) 1997-09-23 2007-11-07 Rentschler Biotechnologie GmbH Flüssige interferon-beta-formulierungen
EP1037995A1 (en) * 1997-12-08 2000-09-27 Genentech, Inc. Human interferon-epsilon: a type 1 interferon
IL139286A (en) 1998-04-28 2005-12-18 Applied Research Systems Polyol-ifn-beta conjugates, their preparation and use
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
ES2317843T3 (es) 1999-07-13 2009-05-01 Bolder Biotechnology, Inc. Proteinas de fusion de eritropoyetina-inmunoglobulina.
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
BR0014486A (pt) * 1999-10-04 2002-09-17 Chiron Corp Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
US6465425B1 (en) 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
WO2002003472A2 (en) 2000-06-29 2002-01-10 California Institute Of Technology Aerosol silicon nanoparticles for use in semiconductor device fabrication
KR100396983B1 (ko) 2000-07-29 2003-09-02 이강춘 고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
PT1345593E (pt) 2000-12-27 2007-10-10 Ares Trading Sa Micropartículas lipídicas por micronização criogénica
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
NZ535008A (en) 2002-02-08 2005-09-30 Alkermes Inc Polymer-based compositions for sustained release
US20040037809A1 (en) 2002-06-28 2004-02-26 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon beta
TWI272948B (en) 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
CN1984673A (zh) 2004-05-17 2007-06-20 阿雷斯贸易股份有限公司 干扰素水凝胶制剂

Also Published As

Publication number Publication date
NO20065860L (no) 2006-12-19
ES2418833T3 (es) 2013-08-16
MXPA06014078A (es) 2007-02-15
EA200602257A1 (ru) 2007-04-27
US20070292391A1 (en) 2007-12-20
UA92146C2 (ru) 2010-10-11
IL179620A0 (en) 2007-05-15
AU2005249233B2 (en) 2010-10-07
WO2005117949A1 (en) 2005-12-15
AU2005249233A1 (en) 2005-12-15
EA010979B1 (ru) 2008-12-30
EP1750751A1 (en) 2007-02-14
JP2008500996A (ja) 2008-01-17
CN1993139B (zh) 2011-02-16
JP4988562B2 (ja) 2012-08-01
EP1750751B1 (en) 2013-04-10
IL179620A (en) 2013-04-30
BRPI0510526A (pt) 2007-10-30
US7731948B2 (en) 2010-06-08
CN1993139A (zh) 2007-07-04
CA2567310A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
HK1102563A1 (en) Stabilized interferon liquid formulations
ZA200706256B (en) Stabilized liquid polypeptide formulations
IL181265A0 (en) Stabilizing formulations
IL177566A0 (en) Pharmaceutical formulations
HK1123188A1 (en) Liquid formulations
EP1773871A4 (en) COMPOUNDS ASSOCIATED WITH TISSUE DIFFERENTIATION FACTOR AND THEIR ANALOGUES
GB0426301D0 (en) Pharmaceutical formulations
GB0423565D0 (en) Formulation
GB0412530D0 (en) Formulation
HK1097751A1 (zh) 無環鳥苷製劑
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
EP1951258A4 (en) LIQUID FORMULATIONS
GB0506035D0 (en) Improved formulation
GB0403769D0 (en) Liquid composition
IL179208A0 (en) Intereferon formulations
GB0417248D0 (en) Formulations
GB0417226D0 (en) Formulations
GB0420820D0 (en) Novel formulations
GB0426295D0 (en) Novel formulations
GB0420817D0 (en) Novel formulations
GB0420818D0 (en) Novel formulations
GB0420821D0 (en) Novel formulations
GB0427249D0 (en) Novel formulations
GB0427248D0 (en) Novel formulations